$Lamotrigine Open Trial in Refractory Epilepsy$

Lamotrigine Open Trial in Refractory Epilepsy

Lamotrigine, 5 and 15 mg/kg/daily, was administered as add-on therapy in 37 outpatient children and adolescents with refractory epilepsy and mental delay treated at the Child Neuropsychiatry Unit, Department of Pediatrics, Second University of Naples, Italy.

Bibliographic Details
Main Author:	J Gordon Millichap
Format:	Article
Language:	English
Published:	Pediatric Neurology Briefs Publishers 1997-10-01
Series:	Pediatric Neurology Briefs
Subjects:	generalized seizures refractory epilepsy seizure frequency
Online Access:	https://www.pediatricneurologybriefs.com/articles/2359

id	doaj-870b395f397945e591f2d5f0075064f5
record_format	Article
spelling	doaj-870b395f397945e591f2d5f0075064f52020-11-25T02:41:50ZengPediatric Neurology Briefs PublishersPediatric Neurology Briefs1043-31552166-64821997-10-011110798010.15844/pedneurbriefs-11-10-132346Lamotrigine Open Trial in Refractory EpilepsyJ Gordon Millichap0Northwestern University Feinberg School of MedicineLamotrigine, 5 and 15 mg/kg/daily, was administered as add-on therapy in 37 outpatient children and adolescents with refractory epilepsy and mental delay treated at the Child Neuropsychiatry Unit, Department of Pediatrics, Second University of Naples, Italy.https://www.pediatricneurologybriefs.com/articles/2359generalized seizuresrefractory epilepsyseizure frequency
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	J Gordon Millichap
spellingShingle	J Gordon Millichap Lamotrigine Open Trial in Refractory Epilepsy Pediatric Neurology Briefs generalized seizures refractory epilepsy seizure frequency
author_facet	J Gordon Millichap
author_sort	J Gordon Millichap
title	Lamotrigine Open Trial in Refractory Epilepsy
title_short	Lamotrigine Open Trial in Refractory Epilepsy
title_full	Lamotrigine Open Trial in Refractory Epilepsy
title_fullStr	Lamotrigine Open Trial in Refractory Epilepsy
title_full_unstemmed	Lamotrigine Open Trial in Refractory Epilepsy
title_sort	lamotrigine open trial in refractory epilepsy
publisher	Pediatric Neurology Briefs Publishers
series	Pediatric Neurology Briefs
issn	1043-3155 2166-6482
publishDate	1997-10-01
description	Lamotrigine, 5 and 15 mg/kg/daily, was administered as add-on therapy in 37 outpatient children and adolescents with refractory epilepsy and mental delay treated at the Child Neuropsychiatry Unit, Department of Pediatrics, Second University of Naples, Italy.
topic	generalized seizures refractory epilepsy seizure frequency
url	https://www.pediatricneurologybriefs.com/articles/2359
work_keys_str_mv	AT jgordonmillichap lamotrigineopentrialinrefractoryepilepsy
_version_	1724777011996524544

Lamotrigine Open Trial in Refractory Epilepsy

Similar Items